JNJ-10397049 is a potent and highly selective OX2 receptor antagonist. In animals, JNJ-10397049 was found to have sleep-promoting effects and to attenuate the reinforcing effects of ethanol.[1][2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H20Br2N2O3 |
Molar mass | 484.188 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, et al. (July 2009). "Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat". The Journal of Pharmacology and Experimental Therapeutics. 330 (1): 142–51. doi:10.1124/jpet.109.152009. PMID 19363060. S2CID 5676758.
- ^ Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, et al. (May 2011). "Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement". Psychopharmacology. 215 (1): 191–203. doi:10.1007/s00213-010-2127-x. PMID 21181123. S2CID 28874886.